Silence Therapeutics plc (SLN) Operating margin 2022–2025
Silence Therapeutics plc (SLN) operating margin by fiscal year — reported operating income divided by reported revenue.
-16292.8%FY2025 · since FY2022: -281.9% → -16292.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -16292.8% | -16146.5 pp |
| FY2024 | -146.4% | +57.1 pp |
| FY2023 | -203.5% | +78.4 pp |
| FY2022 | -281.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice